EUVIMEDEUVIMED entdecken
Open Access

Human brain glycoform coregulation network and glycan modification alterations in Alzheimer’s disease

Qi Zhang iD, Cheng Ma iD, Lih-Shen Chin iD, Sheng Pan, Lian Li iD

Science Advances · 05.04.2024 · 10 (14)

DOI: 10.1126/sciadv.adk6911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 05.04.2024. Verfasst von Qi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the importance of protein glycosylation to brain health, current knowledge of glycosylated proteoforms or glycoforms in human brain and their alterations in Alzheimer’s disease (AD) is limited. Here, we report a proteome-wide glycoform profiling study of human AD and control brains using intact glycopeptide-based quantitative glycoproteomics coupled with systems biology. Our study identified more than 10,000 human brain N-glycoforms from nearly 1200 glycoproteins and uncovered disease signatures of altered glycoforms and glycan modifications, including reduced sialylation and N-glycan branching and elongation as well as elevated mannosylation and N-glycan truncation in AD. Network analyses revealed a higher-order organization of brain glycoproteome into networks of coregulated glycoforms and glycans and discovered glycoform and glycan modules associated with AD clinical phenotype, amyloid-β accumulation, and tau pathology. Our findings provide valuable insights into disease pathogenesis and a rich resource of glycoform and glycan changes in AD and pave the way forward for developing glycosylation-based therapies and biomarkers for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansGlycoproteinsGlycosylationPolysaccharidesBrain

Substanzen

GlycoproteinsPolysaccharides

Autor:innen und Institutionen

  • Department of Pharmacology and Chemical Biology, Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

ORCID-Profile: Qi Zhang, Cheng Ma, Lih-Shen Chin, Lian Li

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Zhang, Q., Ma, C., Chin, L. S., Pan, S., & Li, L. (2024). Human brain glycoform coregulation network and glycan modification alterations in Alzheimer’s disease. Science Advances, 10(14). https://doi.org/10.1126/sciadv.adk6911

Vancouver

Zhang Q, Ma C, Chin LS, Pan S, Li L. Human brain glycoform coregulation network and glycan modification alterations in Alzheimer’s disease. Science Advances. 2024;10(14). doi:10.1126/sciadv.adk6911

BibTeX
@article{Zhang2024,
  author = {Zhang, Qi and Ma, Cheng and Chin, Lih-Shen and Pan, Sheng and Li, Lian},
  title = {Human brain glycoform coregulation network and glycan modification alterations in Alzheimer’s disease},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {14},
  doi = {10.1126/sciadv.adk6911}
}
Kostenlos starten →